China, Emerging Markets To Lead Record $1 Trillion Drug Market In 2014
This article was originally published in PharmAsia News
With China in the lead, the emerging markets are expected to play a major role next year in building a $1 trillion global market for prescribed medicines, according to the IMS Institute for Healthcare Informatics.
You may also be interested in...
The company has no development programs left in its R&D pipeline and will focus entirely on the commercialization of IBS drug Linzess while seeking late-stage assets from external sources.
The documents issued by the US agency on 29 September set slightly different accuracy standards, reflecting the increased fragility of hospital patients.
The US FDA commissioner published a blog post commending and highlighting the work device center staff have done during the pandemic to speed tests and devices to market to save lives.